Updates in Foregut Disease Management: A Multidisciplinary Approach is organized by Methodist Dallas Medical Center (MDMC) and will be held on Feb 08, 2020 at The Westin Irving Convention Center at Las Colinas, Irving, Texas, United States of America.
AMA PRA Category 1 Credit™:
Methodist Health System is accredited by the Texas Medical Association to provide continuing medical education for physicians.
Credit Designation Statement:
Methodist Health System designates this live activity for a maximum of 7.5 credits AMA PRA Category 1 Credit™. This course has been designated by Methodist Health System for 1 credit of education in medical ethics and/or professional responsibility
The fourth Methodist Digestive Institute Symposium brings together nationally recognized experts from a variety of disciplines to share current practices and recent research in relation to foregut disease treatment. Our faculty has been handpicked for their specific expertise in foregut disease from the perspective of gastroenterology, medical oncology, and surgery.
Daylong symposium on foregut disease management will offer seven didactic lectures by nationally renowned medical experts and three livestreamed endoscopic procedure demonstrations and one surgical procedure. Demonstrations will be supplemented by casaes presented by GI fellows and surgery residents with subsequent panel discussions involving the faculty. Topics to be covered include: management of achalasia, endoscopic therapy for Barrett's esophagus, gastric sleeve/bypass during liver transplant, lower esophageal sphincter augmentation for GERD, national trends in multimodal therapy for locally advanced gastric cancer, evolving management strategies for metastatic esophageal and gastroesophageal junction adenocarcinoma, and evolving policies regarding obesity as a disease and their implications (ethics credits).
• Didactic topics presented from three clinical perspectives
• Livestreamed procedure demonstrations
• Relevant case presentations
• Panel discussions
• Ample time for questions and discussion throughout the program with colleagues and faculty
• Relate alternative methodologies for achalasia management strategies; the treatment of patients with Barrett’s esophagus and metastatic esophageal and gastroesophageal junction adenocarcinoma; and multimodal therapy for locally advanced gastric cancer.
• Describe surgical options for gastroesophageal reflux disease treatment and recognize patient selection for anti-reflux surgery.
• Explain the benefits of performing bariatric surgery concurrent with liver transplantation.
• Direct future research into currently expanding subfields of alternative treatments for esophageal and gastroesophageal cancers.
• Bridge the ethical gap between recognizing obesity as a disease and managing it effectively.
Additional details will be posted as soon as information is available.
|Contact No. :||(214) 933-6601
|Registration Type||Last Date||Price|
|Registration Fee||06 Feb,2020||USD 150.00|